This transformation is strongly associated with inactivating mutations in the RB1 and TP53 genes, with triple-mutant adenocarcinomas (EGFR/RB1/TP53) being at higher risk of transformation to SCLC (7). Here, EGFR is linked to adenocarcinoma.